V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210001871 | 210005539 | 1.65 | 48.2 | Palliative (P) | 2016-08-01 | 2016-08-16 | Docetaxel | 02 | N | DOCETAXEL | 101651234 |
| 210001875 | 210005540 | 1.6 | 80.9 | Adjuvant (A) | 2019-02-18 | 2019-02-19 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101680678 |
| 210001877 | 210005541 | 1.66 | 89.5 | Adjuvant (A) | 2016-10-01 | 2016-10-13 | TRASTUZUMAB | null | N | TRASTUZUMAB | 100982440 |
| 210001881 | 210005544 | 1.6 | 74 | Adjuvant (A) | 2017-05-07 | 2017-05-20 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101653470 |
| 210001882 | 210005545 | 1.68 | 71.1 | Palliative (P) | 2018-03-20 | 2018-04-10 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101083076 |
| 210001883 | 210005546 | null | 86.2 | null | 2016-03-29 | 2016-03-30 | Paclitaxel 7 day | null | null | PACLITAXEL | 100454678 |
| 210001885 | 210005548 | null | 86.2 | null | null | 2019-06-06 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101778244 |
| 210001886 | 210005549 | 1.65 | 0 | null | 2017-04-28 | 2017-05-15 | EC | N | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101114052 |
| 210001887 | 210005550 | 1.67 | 88 | Adjuvant (A) | 2020-04-26 | 2020-05-10 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100469930 |
| 210001888 | 210005551 | 1.61 | 58.3 | Adjuvant (A) | 2018-12-09 | 2018-12-29 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100214777 |
| 210001889 | 210005552 | null | 78.6 | null | 2019-01-25 | 2019-01-25 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101281857 |
| 210001890 | 210005553 | 1.59 | 103 | Palliative (P) | 2018-10-16 | 2018-10-17 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101845998 |
| 210001894 | 210005556 | 1.65 | 73.3 | Adjuvant (A) | 2018-09-17 | 2018-09-24 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100128407 |
| 210001896 | 210005557 | 1.74 | 54.6 | Adjuvant (A) | null | 2016-08-19 | Trastuzumab Subcutaneous | null | null | TRASTUZUMAB | 100847812 |
| 210001898 | 210005558 | 1.67 | 87.6 | Adjuvant (A) | null | 2019-12-22 | Docetaxel | null | N | DOCETAXEL | 101838509 |
| 210001899 | 210005559 | 1.6 | 80.55 | Adjuvant (A) | 2017-06-18 | 2017-07-03 | PACLITAXEL | 02 | N | PACLITAXEL | 101822684 |
| 210001900 | 210005560 | 1.62 | 83.5 | Adjuvant (A) | 2017-11-24 | 2017-12-09 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 101096435 |
| 210001904 | 210005562 | 1.7 | 109.2 | Adjuvant (A) | 2018-02-02 | 2018-06-21 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101682778 |
| 210001905 | 210005563 | null | 115.2 | null | 2020-06-20 | 2020-06-30 | PACLITAXEL | 02 | null | PACLITAXEL | 101092237 |
| 210001907 | 210005564 | 1.54 | 75.7 | Palliative (P) | 2020-05-10 | 2020-05-19 | PACLITAXEL | 02 | N | PACLITAXEL | 101084326 |
| 210001908 | 210005565 | 1.48 | 114.8 | Adjuvant (A) | null | 2018-06-29 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100551548 |
| 210001910 | 210005567 | 1.62 | 76.8 | Adjuvant (A) | null | 2017-08-19 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101344946 |
| 210001911 | 210005568 | 1.6 | 55.5 | Adjuvant (A) | 2016-10-21 | 2016-12-30 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100610448 |
| 210001913 | 210005569 | 1.67 | 78.9 | Adjuvant (A) | 2016-10-01 | 2016-10-24 | Paclitaxel 7 day | null | N | PACLITAXEL | 100725129 |
| 210001914 | 210005570 | null | 78.8 | null | 2016-08-28 | 2016-09-07 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101788116 |
| 210001916 | 210005572 | 1.79 | 74.9 | null | 2019-10-28 | 2019-11-05 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100857646 |
| 210001918 | 210005574 | null | null | null | 2017-09-03 | 2017-09-19 | Docetaxel 100mg/m2 (21 day) | 2 | null | DOCETAXEL | 100918533 |
| 210001919 | 210005575 | 1.61 | null | null | 2020-01-18 | 2020-02-03 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100155811 |
| 210001920 | 210005576 | 1.67 | 73.3 | Adjuvant (A) | 2016-04-18 | 2016-04-25 | Trastuzumab | 02 | N | TRASTUZUMAB | 100913842 |
| 210001921 | 210005577 | 1.66 | 58.5 | Adjuvant (A) | 2018-12-05 | 2019-11-12 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100325746 |
| 210001926 | 210005580 | 1.64 | 83 | Adjuvant (A) | 2019-01-20 | 2019-02-12 | Docetaxel | 02 | N | DOCETAXEL | 101793820 |
| 210001931 | 210005584 | 1.61 | 76 | Adjuvant (A) | 2018-08-13 | 2018-08-28 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100778230 |
| 210001933 | 210005585 | 1.67 | 50.7 | Palliative (P) | 2018-05-12 | 2018-05-28 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100117910 |
| 210001934 | 210005586 | null | null | null | 2020-01-23 | 2020-01-29 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100198767 |
| 210001937 | 210005588 | 1.55 | 75.1 | Neo-adjuvant (N) | 2019-12-28 | 2020-01-20 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100444790 |
| 210001938 | 210005589 | 1.61 | 47.5 | Palliative (P) | 2018-08-01 | 2018-08-04 | Trastuzumab | 02 | N | TRASTUZUMAB | 100164492 |
| 210001939 | 210005590 | 1.64 | 61.2 | Adjuvant (A) | 2020-10-11 | 2020-10-18 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101555945 |
| 210001941 | 210005591 | null | null | Palliative (P) | 2018-09-30 | 2018-10-14 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101868409 |
| 210001944 | 210005593 | 1.63 | 75 | Adjuvant (A) | 2016-07-01 | 2016-07-22 | TRASTUZUMAB | N | N | TRASTUZUMAB | 101002234 |
| 210001947 | 210005594 | null | 70.1 | Adjuvant (A) | 2017-08-15 | 2017-08-15 | Trastuzumab | 02 | N | TRASTUZUMAB | 100100151 |
| 210001950 | 210005595 | 1.74 | 87.6 | Adjuvant (A) | 2017-05-20 | 2017-06-15 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101434955 |
| 210001951 | 210005596 | 1.6 | 96.1 | Adjuvant (A) | 2016-04-17 | 2016-05-10 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100028963 |
| 210001952 | 210005597 | 1.51 | 63 | Neo-adjuvant (N) | 2019-06-16 | 2019-06-22 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101179163 |
| 210001954 | 210005599 | null | null | null | 2019-03-28 | 2019-03-29 | Docetaxel 75mg/m2 (21 day) | 01 | null | DOCETAXEL | 101480121 |
| 210001958 | 210005600 | 1.6 | 103 | Palliative (P) | 2019-02-15 | 2019-02-20 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100954947 |
| 210001959 | 210005601 | 1.6 | null | Adjuvant (A) | 2019-10-17 | 2019-11-08 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101566822 |
| 210001960 | 210005602 | 1.68 | 71.1 | Adjuvant (A) | 2016-12-25 | 2017-03-06 | Trastuzumab | null | N | TRASTUZUMAB | 100683049 |
| 210001962 | 210005603 | 1.63 | 60 | Neo-adjuvant (N) | null | 2019-01-03 | Docetaxel | 02 | N | DOCETAXEL | 100208531 |
| 210001963 | 210005604 | 1.52 | 49.2 | Adjuvant (A) | 2019-07-19 | 2019-08-10 | Trastuzumab | 02 | N | TRASTUZUMAB | 101232145 |
| 210001964 | 210005605 | 1.72 | 81 | Palliative (P) | 2016-11-20 | 2016-11-21 | Docetaxel | N | N | DOCETAXEL | 101077026 |